Sichuan Hebang Biotechnology Corporation Limited (SHA:603077)

SHA:603077 Revenue

Sichuan Hebang Biotechnology Corporation had revenue of 1.50B CNY in the quarter ending June 30, 2026, a decrease of -31.66%. This brings the company's total for the last twelve months to 6.15B, down -19.23% year-over-year. In the year 2025, Sichuan Hebang Biotechnology Corporation had annual revenue of 7.19B, down -15.91%. That makes Sichuan Hebang Biotechnology Corporation the 7,974th largest company in the world by revenue and 1,195th in China.

• Revenue (ttm): 6.15B
• Revenue Growth: -19.23%
• P/S Ratio: 2.85
• Revenue / Employee: 1.21M
• Employees: 5,085
• Market Cap: 17.56B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Chemical Industry 6.07B 78.4%
• Glass Manufacturing Industry 1.24B 16.0%
• Photovoltaic Industry 433.26M 5.6%

By Geography

Chart

• Other Parts of The Country 3.86B 50.7%
• Sichuan Province 2.17B 28.4%
• Foreign 955.81M 12.5%
• Southwest China (Except Sichuan) 638.41M 8.4%

Fiscal year ended Dec 31, 2025 See the full SHA:603077 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	7.19B	-1.36B	-15.91%
Dec 31, 2024	8.55B	-276.63M	-3.13%
Dec 31, 2023	8.82B	-4.21B	-32.33%
Dec 31, 2022	13.04B	3.05B	30.55%
Dec 31, 2021	9.99B	4.73B	89.85%

Data Source: S&P Global Market Intelligence Last updated: Aug 17, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 20, 2026

Data Sources Report a data error